AVDL insider transaction filings
AVADEL PHARMACEUTICALS PLC — 49 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-02-18. Screen AVDL transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for AVDL between 2026-06-24 and 2026-09-22. The table below lists the most recent filings on record.
Recent Form 4 filings — AVADEL PHARMACEUTICALS PLC
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-18 | 4 | Weiss Asset Management LP WEISS ANDREW M | Sale (S): 11,112,052 @ $21 | EDGAR |
| 2026-02-12 | 4 | Rodriguez Susan — Chief Operating Officer | Disposition to issuer (D): 300,000 (derivative) | EDGAR |
| 2026-02-12 | 4 | Thornton Peter J. — Director | Disposition to issuer (D): 115,060 @ $21 · Disposition to issuer (D): 60,000 (derivative) · Disposition to issuer (D): 42,000 (derivative) · Disposition to issuer (D): 42,000 (derivative) · Disposition to issuer (D): 42,000 (derivative) · Disposition to issuer (D): 33,000 (derivative) · +2 more | EDGAR |
| 2026-02-12 | 4 | Seurer Jerad G. — Gen. Counsel & Corp. Secretary | Disposition to issuer (D): 23,496 @ $21 · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 30,000 (derivative) · Disposition to issuer (D): 80,000 (derivative) · Disposition to issuer (D): 47,500 (derivative) · Disposition to issuer (D): 100,000 (derivative) · +2 more | EDGAR |
| 2026-02-12 | 4 | Palczuk Linda — Director | Disposition to issuer (D): 78,905 @ $21 · Disposition to issuer (D): 60,000 (derivative) · Disposition to issuer (D): 42,000 (derivative) · Disposition to issuer (D): 42,000 (derivative) · Disposition to issuer (D): 42,000 (derivative) · Disposition to issuer (D): 33,000 (derivative) · +3 more | EDGAR |
| 2026-02-12 | 4 | MCHUGH THOMAS S — Chief Financial Officer | Disposition to issuer (D): 100,400 @ $21 · Disposition to issuer (D): 250,000 (derivative) · Disposition to issuer (D): 200,000 (derivative) · Disposition to issuer (D): 150,000 (derivative) · Disposition to issuer (D): 175,000 (derivative) · Disposition to issuer (D): 157,500 (derivative) · +1 more | EDGAR |
| 2026-02-12 | 4 | McCamish Mark Anthony — Director | Disposition to issuer (D): 22,000 @ $21 · Disposition to issuer (D): 67,025 @ $21 · Disposition to issuer (D): 60,000 (derivative) · Disposition to issuer (D): 42,000 (derivative) · Disposition to issuer (D): 50,000 (derivative) · Disposition to issuer (D): 42,000 (derivative) · +4 more | EDGAR |
| 2026-02-12 | 4 | Glass Geoffrey Michael — Director | Disposition to issuer (D): 22,005 @ $21 · Disposition to issuer (D): 69,075 @ $21 · Disposition to issuer (D): 75,904 @ $21 · Disposition to issuer (D): 60,000 (derivative) · Disposition to issuer (D): 42,000 (derivative) · Disposition to issuer (D): 42,000 (derivative) · +4 more | EDGAR |
| 2026-02-12 | 4 | Ende Eric J — Director | Disposition to issuer (D): 219,905 @ $21 · Disposition to issuer (D): 8,057 (derivative) · Disposition to issuer (D): 60,000 (derivative) · Disposition to issuer (D): 42,000 (derivative) · Disposition to issuer (D): 42,000 (derivative) · Disposition to issuer (D): 42,000 (derivative) · +3 more | EDGAR |
| 2026-02-12 | 4 | Divis Gregory J — Chief Executive Officer, Director | Disposition to issuer (D): 211,105 @ $21 · Disposition to issuer (D): 10,000 @ $21 · Disposition to issuer (D): 150,000 (derivative) · Disposition to issuer (D): 100,000 (derivative) · Disposition to issuer (D): 50,000 (derivative) · Disposition to issuer (D): 100,000 (derivative) · +6 more | EDGAR |
| 2026-02-12 | 4 | Amin Naseem — Director | Disposition to issuer (D): 22,000 @ $21 · Disposition to issuer (D): 49,500 (derivative) · Disposition to issuer (D): 11,000 (derivative) · Disposition to issuer (D): 11,000 (derivative) | EDGAR |
| 2026-02-06 | 4 | McCamish Mark Anthony — Director | Gift (G): 67,025 @ $0 · Gift (G): 67,025 @ $0 | EDGAR |
| 2025-09-15 | 4 | Palczuk Linda — Director | Gift (G): 11,000 (derivative) @ $0 | EDGAR |
| 2025-09-15 | 4 | Glass Geoffrey Michael — Director | Gift (G): 11,000 (derivative) @ $0 | EDGAR |
| 2025-07-31 | 4 | McCamish Mark Anthony — Director | Grant/award (A): 11,000 @ $0 · Grant/award (A): 11,000 (derivative) @ $0 | EDGAR |
| 2025-07-31 | 4 | Palczuk Linda — Director | Grant/award (A): 11,000 @ $0 · Grant/award (A): 11,000 (derivative) @ $0 | EDGAR |
| 2025-07-31 | 4 | Thornton Peter J. — Director | Grant/award (A): 11,000 @ $0 · Grant/award (A): 11,000 (derivative) @ $0 | EDGAR |
| 2025-07-31 | 4 | Glass Geoffrey Michael — Director | Grant/award (A): 11,000 @ $0 · Grant/award (A): 11,000 (derivative) @ $0 | EDGAR |
| 2025-07-31 | 4 | Ende Eric J — Director | Grant/award (A): 11,000 @ $0 · Grant/award (A): 11,000 (derivative) @ $0 | EDGAR |
| 2025-07-31 | 4 | Amin Naseem — Director | Grant/award (A): 11,000 @ $0 · Grant/award (A): 11,000 (derivative) @ $0 | EDGAR |
| 2025-05-13 | 4 | Rodriguez Susan — Chief Operating Officer | Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
| 2025-03-07 | 4 | Seurer Jerad G. — Gen. Counsel & Corp. Secretary | Grant/award (A): 14,700 @ $0 · Grant/award (A): 84,000 (derivative) @ $0 | EDGAR |
| 2025-03-07 | 4 | MCHUGH THOMAS S — Chief Financial Officer | Grant/award (A): 12,600 @ $0 · Grant/award (A): 72,000 (derivative) @ $0 | EDGAR |
| 2025-03-07 | 4 | Divis Gregory J — Chief Executive Officer, Director | Grant/award (A): 52,000 @ $0 · Grant/award (A): 310,000 (derivative) @ $0 | EDGAR |
| 2025-01-28 | 4 | Palczuk Linda — Director | Gift (G): 25,000 (derivative) @ $0 | EDGAR |
| 2025-01-22 | 4 | Palczuk Linda — Director | Purchase (P): 5,000 @ $7.93 | EDGAR |
| 2025-01-14 | 4 | Thornton Peter J. — Director | Purchase (P): 10,000 @ $8.04 | EDGAR |
| 2025-01-14 | 4 | Ende Eric J — Director | Purchase (P): 30,000 @ $7.84 | EDGAR |
| 2024-12-27 | 4 | Palczuk Linda — Director | Gift (G): 3,500 @ $0 | EDGAR |
| 2024-12-19 | 4 | Palczuk Linda — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2024-12-16 | 4 | MCHUGH THOMAS S — Chief Financial Officer | Purchase (P): 2,300 @ $10.44 | EDGAR |
| 2024-12-12 | 4 | MCHUGH THOMAS S — Chief Financial Officer | Purchase (P): 5,000 @ $10.49 | EDGAR |
| 2024-12-10 | 4 | Divis Gregory J — Chief Executive Officer, Director | Purchase (P): 9,598 @ $9.98 · Purchase (P): 402 @ $9.82 | EDGAR |
| 2024-12-10 | 4 | Glass Geoffrey Michael — Director | Purchase (P): 10,075 @ $9.89 · Purchase (P): 10,204 @ $9.80 | EDGAR |
| 2024-12-10 | 4 | Palczuk Linda — Director | Purchase (P): 3,000 @ $10.19 | EDGAR |
| 2024-09-16 | 4 | Palczuk Linda — Director | Gift (G): 11,000 (derivative) @ $0 | EDGAR |
| 2024-09-13 | 4 | Glass Geoffrey Michael — Director | Gift (G): 11,000 (derivative) @ $0 | EDGAR |
| 2024-08-01 | 4 | Palczuk Linda — Director | Grant/award (A): 11,000 @ $0 · Grant/award (A): 11,000 (derivative) @ $0 | EDGAR |
| 2024-08-01 | 4 | Thornton Peter J. — Director | Grant/award (A): 11,000 @ $0 · Grant/award (A): 11,000 (derivative) @ $0 | EDGAR |
| 2024-08-01 | 4 | Ende Eric J — Director | Grant/award (A): 11,000 @ $0 · Grant/award (A): 11,000 (derivative) @ $0 | EDGAR |
| 2024-08-01 | 4 | Amin Naseem — Director | Grant/award (A): 11,000 @ $0 · Grant/award (A): 11,000 (derivative) @ $0 | EDGAR |
| 2024-08-01 | 4 | McCamish Mark Anthony — Director | Grant/award (A): 11,000 @ $0 · Grant/award (A): 11,000 (derivative) @ $0 | EDGAR |
| 2024-08-01 | 4 | Glass Geoffrey Michael — Director | Grant/award (A): 11,000 @ $0 · Grant/award (A): 11,000 (derivative) @ $0 | EDGAR |
| 2024-05-21 | 4 | Amin Naseem — Director | Grant/award (A): 49,500 (derivative) @ $0 | EDGAR |
| 2024-03-04 | 4 | Kim Richard J — Chief Commercial Officer | Grant/award (A): 147,000 (derivative) @ $0 | EDGAR |
| 2024-03-04 | 4 | MCHUGH THOMAS S — Chief Financial Officer | Grant/award (A): 157,500 (derivative) @ $0 | EDGAR |
| 2024-03-04 | 4 | Divis Gregory J — Chief Executive Officer, Director | Grant/award (A): 600,000 (derivative) @ $0 | EDGAR |
| 2024-01-16 | 4 | MCHUGH THOMAS S — Chief Financial Officer | Purchase (P): 2,000 @ $14.50 | EDGAR |
| 2023-12-29 | 4 | McCamish Mark Anthony — Director | Sale (S): 75,000 @ $14.53 | EDGAR |
Recent 8-K events — AVADEL PHARMACEUTICALS PLC
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-02-12 | 8-K | 1.02 — Termination of a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-20 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-01-12 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-18 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-09 | 8-K | 8.01 — Other Events | EDGAR |
| 2025-11-19 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-17 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-14 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-04 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-22 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=AVDL returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →